GRAIL Says Galleri Demand Is Rising as NHS Talks, FDA Review Move Ahead
GRAIL, Inc. (GRAL) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Zaya Younan Unveils the Scientific Holy Grail of Cigar Smoking
GRAIL, Inc. (GRAL) Q1 2026 Earnings Call Transcript
GRAIL Reports First Quarter 2026 Financial Results
GRAIL to Present at the BofA Securities 2026 Health Care Conference
Will Ultragenyx (RARE) Report Negative Q1 Earnings? What You Should Know
GRAIL to Announce First Quarter 2026 Financial Results
GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at 2026 ASCO Annual Meeting
GRAL DROPS ~50% -- REPORTED NUMBERS VS. ACTUAL RESULTS; LEVI & KORSINSKY, LLP INVESTIGATES
GRAIL, Inc. $GRAL Shares Sold by Carnegie Investment Counsel
Aaron Freidin Sells 45,806 Shares of GRAIL (NASDAQ:GRAL) Stock
Joshua Ofman Sells 61,665 Shares of GRAIL (NASDAQ:GRAL) Stock
Robert Ragusa Sells 123,502 Shares of GRAIL (NASDAQ:GRAL) Stock
GRAIL Partners With Epic to Broaden Galleri Test Access Across US
Grail, Epic Plan Galleri Test Integration For 450 Health Systems
GRAIL: NHS-Galleri Trial Results Are A Foul Ball, Not A Strikeout
GRAIL Announces Integration of the Galleri® Test into Epic Electronic Health Record Platform to Expand Access Nationwide
Better Healthcare Stock to Own in a Recession: Defensive or Growth?
GRAL Investors Have Opportunity to Join GRAIL, Inc. Fraud Investigation with the Schall Law Firm
Cancer Is Striking Earlier -- Superpower and GRAIL Are Partnering to Expand Early Detection
GRAL DROPS ~50% -- REPORTED NUMBERS VS. ACTUAL RESULTS; LEVI & KORSINSKY, LLP INVESTIGATES
Here's Why Grail Stock Soared Higher This Week
GRAL DROPS ~50% -- REPORTED NUMBERS VS. ACTUAL RESULTS; LEVI & KORSINSKY, LLP INVESTIGATES
This Investor Exited a $22 Million GRAIL Stake Before a 50% One-Day Stock Crash Last Month
Here's Why Grail Shares Crushed the Market This Week
Trump Is No Crusader for Markets. Why the Fed Failed to Deliver the Holy Grail.
LEVI & KORSINSKY, LLP: GRAIL (GRAL) GUIDED TO 2030 CASH RUNWAY WHILE KEY TRIAL RISK WENT UNADDRESSED
GRAIL, Inc. (NASDAQ:GRAL) Receives Consensus Recommendation of “Hold” from Analysts
Grail CEO Bob Ragusa to retire, Josh Ofman named successor
GRAIL Announces Retirement of CEO Bob Ragusa and Appointment of Josh Ofman, MD, MSHS, as Successor
Here's Why Grail Shares Crashed in February and Why it Could Be a Buying Opportunity
Levi & Korskinsky, LLP: Grail (GRAL) Guided to 2030 Cash Runway While Key Trial Risk Went Unaddressed
GRAL DROPS ~50% -- REPORTED NUMBERS VS. ACTUAL RESULTS; LEVI & KORSINSKY, LLP INVESTIGATES
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Levi & Korsinsky Investigates GRAIL, Inc. (GRAL) Over Possible Securities Fraud
GRAIL to Present at the TD Cowen 46th Annual Health Care Conference
Lost Money on GRAIL, Inc. (GRAL)? Possible Fraud - Contact Levi & Korsinsky Today
Here's Why Grail Stock Bounced Back 16% Today
GRAL INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Launches Investigation into GRAIL, Inc., Encourages Investors and Potential Witnesses to Contact Law Firm
Stock Traders Buy Large Volume of Call Options on GRAIL (NASDAQ:GRAL)
Why Grail Shares Are Plummeting
Here's Why Grail Stock Slumped Again Today
This Fund Bet Nearly $40 Million on GRAIL Last Quarter. The Stock Just Plunged Over 50%
GRAIL Stock Tumbles — National Health Service Galleri Trial To Blame
'Holy Grail' Honus Wagner card sells for over $5M as family auctions it from grandfather's collection
GRAIL, Inc. (NASDAQ:GRAL) Receives $107.83 Consensus Price Target from Brokerages
Grail Shares Crashes 50% After Major Cancer Screening Trial Fails Main Goal
This once-hot cancer-detection company's stock got cut in half after a failed trial
GRAL ALERT: Investigation Launched into GRAIL, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm